Ashley Ivor Simon Morris
Nessuna posizione attualmente
Profilo
Ashley Ivor Simon Morris served as the Area Director at PT Organon Pharma Indonesia Tbk from 2004 to 2009.
In 2017, he briefly served as the Chief Executive Officer & Executive Director at SciGen Pte Ltd.
Morris obtained his undergraduate degree from The University of Nottingham in 2013.
Precedenti posizioni note di Ashley Ivor Simon Morris
| Società | Posizione | Fine |
|---|---|---|
| SCIGEN LIMITED | Amministratore Delegato | 08/09/2017 |
| MERCK SHARP DOHME PHARMA TBK PT | Corporate Officer/Principal | 01/01/2009 |
Formazione di Ashley Ivor Simon Morris
| The University of Nottingham | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK SHARP DOHME PHARMA TBK PT | Health Technology |
| Aziende private | 1 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Ashley Ivor Simon Morris
